For example, engineered exosomes can target M2 macrophages and induce M2-to-M1 polarization, activate CD8+ T cells and B cells, stimulate antigen-specific CD8+ T cells or kill tumors directly with b cell-derived antibodies, enhance tumor antigen presentation, and enhance antitumor immune responses. The gene discussed is CD8A; the disease is neoplasm.